Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read Healthcare Industry News NeoGenomics launches PanTracer Tissue and HRD-enhanced profiling to accelerate ovarian cancer treatment decisions NeoGenomics launches PanTracer Tissue and PanTracer Tissue + HRD to fast-track ovarian cancer treatment with next-gen genomic profiling and rapid HRD testing. byPallavi MadhirajuJuly 2, 2025